Abstract
Significant advances in understanding of P2X purinoceptor pharmacology have been made in the last few years. The limitations of nucleotide agonists as drug tools have now been amply demonstrated. Fortunately, inhibitors of the degrading ecto-ATPase enzymes are becoming available and it has become apparent that the complete removal of all divalent cations can be used experimentally in some systems to prevent nucleotide breakdown. Despite these issues, convincing evidence for P2X receptor heterogeneity, from data with agonists, has recently been reported.
A number of new antagonists at P2X purinoceptors have also recently been described which to some degree appear to be more specific and useful than earlier antagonists like suramin. It is now apparent that suramin is a poor antagonist of ATP in many tissues because it potently inhibits ATPase activity at similar concentrations to those at which it blocks the P2X purinoceptor.
Advances in the use of radiolabelled nucleotides as radioligands for binding studies has allowed the demonstration of P2X purinoceptors in a variety of tissues throughout the body including the brain. These studies have also provided evidence for receptor heterogeneity. Excitingly, two P2X purinoceptor genes have been cloned but operational studies suggest that more than two types exist. The cloning studies have also demonstrated a unique structure for the P2X purinoceptor which differentiates it from all other ligand-gated ion channel receptors. Further studies on P2X purinoceptor operation and structure are needed to help resolve controversies alluded to regarding the characterization and classification of nucleotide receptors. Hopefully such studies will also lead to a better understanding of the physiological and pathological importance of ATP and its activation of P2X purinoceptors. This will require the identification of better drug tools, in particular antagonists which may also provide the basis for novel therapeutic agents.
Similar content being viewed by others
References
Abbrachio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors. Pharmacol Ther 64:445–475
Allgaier C, Wellmann H, Schobert A, Kurz G, von Kügelgen I (1995) Cultured chick sympathetic neurons: ATP-induced noradrenaline release and its blockade by nicotinic receptor antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 252:25–30
Bailey SJ, Hourani SMO (1994) Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br J Phannacol 112:219–225
Barajas-Lopez C, Espinosa-Luna R, Gerzanich V (1994) ATP closes and opens a cationic conductance through different receptors in neurons of guinea-pig submucous plexus. J Pharmacol Exp Ther 268:1396–1402
Bean BP (1990) ATP-activated channels in rat and bullfrog sensory neurons: concentration dependence and kinetics. J Neurosci 10:1–10
Bean BP (1992) Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol Sci 13:87–90
Benham CD, Tsien RW (1987) A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle. Nature 328:275–278
Bo X, Burnstock G (1990) High- and low-affinity binding sites for [3H]-α,β-methylene ATP in rat urinary bladder membranes. Br J Pharmacol 101:291–296
Bo X, Burnstock G (1993) Heterogeneous distribution of [3H]α,β-methylene ATP binding sites in blood vessels. J Vase Res 30:87–101
Bo X, Simon J, Burnstock G, Barnard EA (1992) Solubilization and molecular size determination of the P2X purinoceptor from rat vas deferens. J Biol Chem 267:171581–171587
Bo X, Fischer B, Maillard M, Jacobsen KA, Burnstock G (1994) Comparative studies on the affinities of ATP derivatives for P2X purinoceptors in rat urinary bladder. Br J Pharmacol 112:1151–1159
Boyer JL, Zohn IE, Jacobson KA, Harden TK (1994) Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors. Br J Pharmacol 113:614–620
Brake A, Wagenbach M, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519–523
Bültmann R, Starke K (1993) Evans blue blocks P2X-purinoceptors in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:684–687
Bültmann R, Starke K (1994a) P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:74–80
Bültmann R, Starke K (1994b) Blockade by 4,4′-diisothiocyanatostil-bene-2,2′-disulphonate (DIDS) of P2X-purinoceptors in rat vas deferens. Br J Pharmacol 112:690–694
Bültmann R, Trendelenburg M, Starke K (1994) Blockade of P2X-purinoceptors by trypan blue in rat vas deferens. Br J Pharmacol 113:349–354
Bültmann R, Driessen B, Gonçalves J, Starke K (1995) Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue. Naunyn-Schmiedeberg's Arch Pharmacol 351:555–560
Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509–581
Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433–440
Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger J-D, Rossier BC (1994) Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367:463–467
Cascalheira JF, Sebastião AM (1992) Adenine nucleotide analogues, including γ-phosphate-substituted analogues, are metabolised extracellularly in innervated frog sartorius muscle. Ear J Pharmacol 222:49–59
Cloues R (1995) Properties of ATP-gated channels recorded from rat sympathetic neurons: voltage dependence and regulation by Zn2+ ions. J Neurophysiol 73:312–319
Cloues R, Jones S, Brown DA (1993) Zn2+ potentiates ATP-activated currents in rat sympathetic neurons. Pflügers Arch 424:152–158
Coleman RA, Humphrey PPA (1993) Prostanoid receptors: their function and classification. In: Vane JR, O'Grady J (eds) Therapeutic applications of prostaglandins. Edward Arnold, London, pp 15–36
Coleman RA, Smith WL, Narumiya S (1994) Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205–229
Crack BE, Beukers MW McKechnie KCW, Ijzerman AP, Leff P (1994) Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br J Pharmacol 113:1432–1438
Crack BE, Pollard CE, Beakers SM, Roberts SM, Hunt SF, Ingall AH, McKechnie KCW, Ijzerman AP, Leff P (1995) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 114:475–481
Cusack NJ, Pearson JD, Gordon JL (1983) Stereoselectivity of ecto-nucleotidases on vascular endothelial cells. Biochem J 214:975–981
Dalziel HH, Westfall DP (1994) Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol Rev 46:449–466
Dudeck O, Bültmann R, Starke K (1995) Two relaxation-mediating P2-purinoceptors in guinea-pig taenia caeci. Naunyn-Schmiedeberg's Arch Pharmacol 351:107–110
Edwards FA, Gibb AJ, Colquhoun D (1992) ATP receptor-mediated synaptic currents in the central nervous system. Nature 359:144–147
Evans RJ, Kennedy C (1994) Characterization of P2-purnoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br J Pharmacol 113:853–860
Evans RJ, Derkach V, Surprenant A (1992) ATP mediates fast synaptic transmission in mammalian neurons. Nature 357:503–505
Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X-purinoceptors). Mol Pharmacol 48:178–183
Fieber LA, Adams DJ (1991) Adenosine triphosphate-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. J Physiol (Loud) 434:239–256
Fischer B, Boyer JL, Hoyle CHV, Ziganshin AU, Brizzolara AL, Knight GE, Zimmer J, Burnstock G, Harden TK, Jacobsen KA (1993) Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate. J Med Chem 36:3937–3946
Fredholm BB, Abbrachio MP, Burnstock G, Daly JW Harden TK, Jacobson KA, Leff P, Williams M (1994) VI Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143–155
Hourani SMO, Chown JA (1989) The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea pig urinary bladder. Gen Pharmacol 20:413–416
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) The IUPHAR Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol Rev 46:157–203
Hoyle CHV, Knight GE, Burnstock G (1990) Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99:617–621
Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233–236
Inoue K, Brading AF (1990) The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br J Pharmacol 100:619–625
Juul B, Löscher ME, Aalkjear C, Plesner L (1991) Nucleotide hydrolytic activity of isolated intact rat mesenteric small arteries. Biochim Biophys Acta 1067:201–207
Khakh BS, Michel AD, Humphrey PPA (1994) Estimates of affinities at P2X-purinoceptors in rat vas deferens. Eur J Pharmacol 263:301–309
Khakh BS, Humphrey PPA, Surprenant A (1995a) Electrophysiological properties of P2X purinoceptors in rat superior cervical, nodose and guinea pig coeliac neurones. J Physiol (Lond) 484:385–395
Khakh BS, Michel AD, Humphrey PPA (1995b) Inhibition of ectoATPase and Ca-ATPase in rat vas deferens by P2-purinoceptor antagonists. Br J Pharmacol 115:2P
Khakh BS, Surprenant A, Humphrey PPA (1995c) The use of agonists to characterize P2x-purinoceptors mediating electrophysiological and mechanical responses of rat vas deferens. Br J Pharmacol 115:177–185
Khakh BS, Humphrey PPA, Surprenant A (dy1995d) Actions of antagonists against inward currents induced by ATP in rat nodose neurones. Br J Pharmacol 194:402P
Knowles AF (1988) Differential expression of ectoMg2+-ATPase and ectoCa2+-ATPase activities in human hepatoma cells. Arch Biochem Biophys 263:264–271
Knowles AF, Isler RE, Reece JF (1983) The common occurrence of ATP diphosphohydrolase in mammalian plasma membranes. Biochem Biophys Acta 731:88–96
von Kügelgen I, Bültmann R, Starke K (1990) Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP. Naunyn-Schmiedeberg's Arch Pharmacol 342:198–205
Lambrecht G, Friebe T, Grimm U, Windshief U, Bungardt E, Hilderbrandt C, Bumert HG, Spatz-Kum-Bel G, Mutschler E (1992) PPADS, a novel functionally selective antagonist of P2 purinoceptor mediated responses. Fur J Pharmacol 217:217–219
Leff P, Wood BE, O'Connor SE (1990) Suramin is a slowly-equilibrating but competitive antagonist at P2X-receptors in the rabbit isolated ear artery. Br J Pharmacol 101:645–649
McKechnie KCW, Crack BE, Dainty I, Leff P (dy1995) The effects of ectoATPase inhibition on agonist potency orders at P2Y and P2X purinoceptors. Br J Pharmacol 114:104P
McLaren GJ, Sneddon P, Kennedy C, Lambrecht G, Burnstock G, Mutschler E, Bumert HG, Hoyle CHV (1993) Investigation of a putative P2X-purinoceptor antagonist in guinea pig isolated vas deferens. Br J Pharmacol 109:109P
Michel AD, Humphrey PPA (1993) Distribution and characterization of [3H]α,β-meATP binding sites in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 348:608–617
Michel AD, Humphrey PPA (1994) Effects of metal cations on [3H]α,β-methylene ATP binding in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 350:113–122
Michel AD, Humphrey PPA (1995) High affinity binding sites for [35S]ATPyS in rat vas deferens may be PX purinoceptors. Br J Pharmacol 115:1P
Michel AD, Trezise DJ, Grahames CBA, Khakh BS, Humphrey PPA (1994) The selective P2X purinoceptor agonist, β,γ-methylene l-ATP, discriminates between smooth muscle and neuronal P2X purinoceptors. Br J Pharmacol 113:5βP
Michel AD, Chan N-M, Fan T-PD, Frost EE, Humphrey PPA (1995) Evidence that [3H]αβ meATP may label an endothelial-derived cell line 5′-nucleotidase with high affinity. Br J Pharmacol 115:767–774
Murrin RJA, Boarder MR (1992) Neuronal “nucleotide” receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP. Mol Pharmacol 41:561–568
Nagy A (1986) Enzymatic characteristics and possible role of synaptosomal ecto-adenosine triphosphatase from mammalian brain. In: Kreutzberg GW (ed) Cellular biology of ectoenzymes. Springer, Berlin Heidelberg New York, pp 49–59
Nakazawa K, Fujimori K, Takanaka A, Inoue K (1990) An ATP activated conductance in phaeochromocytoma cells and its suppression by extracellular calcium. J Physiol (Lond) 428:257–272
Nakazawa K, Inoue K, Fujimori K, Takanaka A (1991) Effects of ATP antagonists on purinoceptor-operated inward currents in rat phaeochromocytoma cells. Pflügers Arch 418:214–219
Nakazawa K, Inoue K, Ito K, Koizumi K, Inoue K (1995) Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 351:202–208
O'Connor SE, Wood BE, Leff P (1990) Characterization of P2x-receptors in rabbit isolated ear artery. Br J Pharmacol 101:640–644
Owens GP, Hahn WE, Cohen JJ (1991) Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11:4177–4188
Pearson JD (1986) Ectonucleotidases of vascular endothelial cells: characterization and possible physiological roles. In: Kreutzberg GW (ed) Cellular biology of ectoenzymes. Springer, Berlin Heidelberg New York, pp 17–25
Silinsky EM, Gerzanich V (1993) On the excitatory effects of ATP and its role as a neurotransmitter in coeliac neurones of the guinea-pig. J Physiol (Lond) 464:197–212
Snell EE, Dimari SJ (1980) Schiff base intermediates in enzyme catalysis. In: Boyer PD (ed) The enzymes (vol 12). Academic, New York, pp 335–370
Surprenant A, Buell G, North RA (1995) P2X receptor brings new structure to ligand gated ion channels. Trends Neurosci 18:224–229
Trezise DJ, Kennedy I, Humphrey PPA (1993) Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br J Pharmacol 110:1055–1060
Trezise DJ, Bell NJ, Kennedy I, Humphrey PPA (1994a) Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification. Br J Pharmacol 113:463–470
Trezise DJ, Kennedy I, Humphrey PPA (1994b) The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by α,β-methylene adenosine 5′-triphosphate. Br J Pharmacol 112:282–288
Trezise DJ, Bell NJ, Khakh BS, Michel AD, Humphrey PPA (1994c) P2 purinoceptor properties of pyridoxal-5′-phosphate. Eur J Pharmacol 259:295–300
Trezise DJ, Bell NJ, Humphrey PPA (1994d) P2 purinoceptor antagonist effects of pyridoxal-5-phosphate in the rat vagus nerve and guinea-pig aorta. Br J Pharmacol 112:502P
Trezise DJ, Michel AD, Grahames CBA, Khakh BS, Surprenant A, Humphrey PPA (1995) The selective P2X purinoceptor agonist, βγ-methylene-L-adenosine 5′-triphosphate, discriminates between smooth muscle and neuronal P2X purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 351:603–609
Valera S, Hussy N, Evans RJ, Adami N, North A, Surprenant A, Buell G (1994) A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 371:516–519
Valera S, Talabot F, Evans RJ, Gos A, Antonarakis SE, Morris MA, Buell G (1995) Characterization and chromosomal localization of a human P2X receptor from urinary bladder. Receptors Channels (in press)
Venkova K, Milne A, Krier J (1994) Contraction mediated by α1-adrenoceptors and P2-purinoceptors in cat colon circular muscle. Br J Pharmacol 112:1237–1243
Vials AJ, Burnstock G (1994) The effect of suramin on vasodilator responses to ATP and 2-methylthio-ATP in the Sprague-Dawley rat coronary vasculature. Eur J Pharmacol 251:299–302
Voogd TE, Vansterkenburg EL, Wilting J, Janssen LH (1993) Recent research on the biological activity of suramin. Pharmacol Rev 45:177–203
Walker JE, Saraste M, Runswick MJ, Gay NJ (1982) Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1:945–951
Welford LA, Cusack NJ, Hourani SMO (1986) ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor. Eur J Pharmacol 129:217–224
Welford LA, Cusack NJ, Hourani SMO (1987) The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol 141:123–130
Wilkinson GF, Purkiss JR, Boarder MR (1993) The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2Y-purinoceptors and nucleotide receptors linked to phospholipase C. Br J Pharmacol 108:689–693
Windschief U, Ralevic V, Bumert HG, Mutschler E, Lambrecht G, Burnstock G (1994) Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions via P2x- purinoceptors. Br J Pharmacol 113:1015–1021
Yagi K, Arai Y, Kato N, Hirota K, Miura Y (1991) ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells. Biochem Biophys Res Commun 180:1200–1206
Ziganshin AU, Hoyle CHV, Bo X, Lambrecht G, Mutschler E, Bu-G, Burnstock G (1993) PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol 110:1491–1495
Ziganshin AU, Hoyle CHV Burnstock G (1994) Ecto-enzymes and metabolism of extracellular ATP. Drug Dev Res 32:134–146
Ziganshin AU, Ziganshina LE, King BE Burnstock G (1995) Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflügers Arch 429:412–418
Zimmermann H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345–365
Zimmet J, Jrlebark L, Hammarberg T, van Galen PJM, Jacobsen KA, Heilbronn E (1993) Synthesis and biological activity of novel 2-thio derivatives of ATP. Nucleos Nucleot 12:1–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Humphrey, P.P.A., Buell, G., Kennedy, I. et al. New insights on P2X purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 352, 585–596 (1995). https://doi.org/10.1007/BF00171316
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171316